Skip to main content

Table 2 Effects of celecoxib administration (50 mg/kg/day, orally), and celecoxib plus royal jelly administration (300 mg/kg/day, orally) in comparison to the control group, on serum MDA and SOD in male albino rats. Data are expressed as mean ± SD, n = 10/group

From: Cardioprotective role of royal jelly in the prevention of celecoxib-mediated cardiotoxicity in adult male albino rats

Groups

MDA (nmol/mL)

SOD (U/mL)

1

5.86 ± 0.66c

5.40 ± 0.62a

2

28.10 ± 3.48a

0.89 ± 0.68c

3

16.03 ± 2.51b

3.20 ± 0.61b

  1. Group (1) received no drug (control). Group (2) received celecoxib (50 mg/kg/day, orally), for 30 successive days. Group (3) received celecoxib (50 mg/kg/day, orally) and royal jelly (300 mg/kg/day, orally) for 30 successive days. Means carrying different superscripts in the same column are significant at p < 0.05